Five Prime Therapeutics Inc (NASDAQ:FPRX)

During the Trading Day
11.46 -0.46 / -3.86%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
11.46 +0.0014 / +0.01%
Volume: 4.3K
Health Technology

Company Description

Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on discovering and developing novel protein therapeutics. It is building a pipeline of oncology and immunology drug by using its discovery platform. The company was founded in December 2001 by Lewis T. Williams and is headquartered in South San Francisco, CA.

Contact Information

Five Prime Therapeutics, Inc.
Two Corporate Drive
South San Francisco California 94080-7047
P:(415) 365-5600
Investor Relations:



Other institutional31.25%
Mutual fund holders16.78%
Individual stakeholders11.99%

Top Executives

Lewis T. WilliamsPresident, Chief Executive Officer & Director
Marc L. BelskyChief Financial Officer & Senior Vice President
William Michael KavanaughChief Scientific Officer & Senior VP-Research
Julie HambletonChief Medical Officer & Senior Vice President
Aron M. KnickerbockerDirector, Chief Business Officer & Senior VP

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.